Article citationsMore>>

Han, Y. and Tu, P. (2022) Baricitinib Is Potentially Effective in the Treatment of Refractory Livedoid Vasculopathy. Frontiers in Immunology, 13, Article 1008392.
https://doi.org/10.3389/fimmu.2022.1008392

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top